# NALMEFENE HYDROCHLORIDE
> **ANDA212955** · Abbreviated New Drug Application (Generic) · Sponsor: PURDUE PHARMA LP · Approved 2022-02-08
## Drug
- **FDA Application Number:** ANDA212955
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALMEFENE HYDROCHLORIDE
- **Generic name:** NALMEFENE HYDROCHLORIDE
- **Active ingredients:** NALMEFENE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** PURDUE PHARMA LP
- **Manufacturer:** Knoa Pharma LLC
- **First approval:** 2022-02-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212955)
---
*MORVS · CC0 1.0*